APGE
Apogee Therapeutics Inc.
Latest News for APGE
In a report released on April 2, Julian Harrison from BTIG reiterated a Buy rating on Apogee Therapeutics, with a price target of $137.00. The comp......
In a report released on April 2, Julian Harrison from BTIG reiterated a Buy rating on Apogee Therapeutics, with a price target of $137.00. The comp......
Guggenheim analyst Seamus Fernandez reiterated a Buy rating on Apogee Therapeutics yesterday and set a price target of $160.00. The company’s share......
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Apogee Therapeutics (APGE) and Theriva Biologics (......
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amgen (AMGN), Apogee Therapeutics (APGE) and Gilead Sciences (GIL......
Traders seeking the top stock market stories for Monday will find them in the TipRanks daily wrap-up. ...
Apogee Therapeutics stock gained on Monday alongside strong results from the company’s latest clinical trial. ...
Apogee Therapeutics stock gained on Monday alongside strong results from the company’s latest clinical trial. ...
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Beta Bionics, Inc. (BBNX), Apogee Therapeutics (APGE......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Beta Bionics, Inc. (BBNX), Apogee Therapeutics (APGE......
News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 12 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | APGE | $82.98 | -0.4% | 567.72K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Apogee Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW